Skip to main content
. Author manuscript; available in PMC: 2017 Apr 3.
Published in final edited form as: Nat Rev Clin Oncol. 2016 Oct 11;14(3):169–186. doi: 10.1038/nrclinonc.2016.162

graphic file with name emss-71926-f006.jpg

A patient with a metastatic neuroendocrine tumour undergoing a diagnostic 68Ga-dotatate PET–CT has a | multiple disease sites on fused coronal images, and b | maximum intensity projection. The patient then received therapeutic 177Lu-dotatate, which enables demonstration of drug uptake at the disease sites, confirmed by SPECT– CT examination on c | fused coronal images and d | maximum intensity projection.